David Cerna

1.3k total citations
22 papers, 1.1k citations indexed

About

David Cerna is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, David Cerna has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in David Cerna's work include DNA Repair Mechanisms (5 papers), Epigenetics and DNA Methylation (5 papers) and PARP inhibition in cancer therapy (4 papers). David Cerna is often cited by papers focused on DNA Repair Mechanisms (5 papers), Epigenetics and DNA Methylation (5 papers) and PARP inhibition in cancer therapy (4 papers). David Cerna collaborates with scholars based in United States, India and United Kingdom. David Cerna's co-authors include Kevin Camphausen, Philip J. Tofilon, William Burgan, C. Norman Coleman, Sanjeewani T. Palayoor, Molykutty John‐Aryankalayil, Michael Cerra, David K. Wilson, Michael T. Falduto and Scott R. Magnuson and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Cancer Research.

In The Last Decade

David Cerna

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Cerna United States 18 750 297 250 166 157 22 1.1k
Estefanía Carrasco‐García Spain 25 817 1.1× 387 1.3× 412 1.6× 223 1.3× 116 0.7× 37 1.4k
William Burgan United States 22 1.4k 1.9× 575 1.9× 259 1.0× 298 1.8× 309 2.0× 27 1.9k
Sandaruwan Geeganage United States 11 626 0.8× 361 1.2× 195 0.8× 120 0.7× 179 1.1× 21 1.0k
Viney Jain India 13 649 0.9× 190 0.6× 630 2.5× 157 0.9× 189 1.2× 26 1.2k
Hyun Min Jeon South Korea 13 657 0.9× 355 1.2× 445 1.8× 44 0.3× 134 0.9× 18 1.1k
Carmen Dekmezian United States 6 560 0.7× 491 1.7× 425 1.7× 142 0.9× 85 0.5× 8 974
Gabriele D. Maurer Germany 17 671 0.9× 214 0.7× 385 1.5× 289 1.7× 83 0.5× 36 1.2k
Yasir H. Ibrahim United States 12 1.1k 1.4× 828 2.8× 249 1.0× 145 0.9× 305 1.9× 22 1.6k
Nathan G. Dolloff United States 19 877 1.2× 515 1.7× 296 1.2× 100 0.6× 148 0.9× 41 1.4k

Countries citing papers authored by David Cerna

Since Specialization
Citations

This map shows the geographic impact of David Cerna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cerna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cerna more than expected).

Fields of papers citing papers by David Cerna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Cerna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cerna. The network helps show where David Cerna may publish in the future.

Co-authorship network of co-authors of David Cerna

This figure shows the co-authorship network connecting the top 25 collaborators of David Cerna. A scholar is included among the top collaborators of David Cerna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Cerna. David Cerna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cerna, David, Bora Lim, Stephen Yoo, et al.. (2021). SMAC Mimetic/IAP Inhibitor Birinapant Enhances Radiosensitivity of Glioblastoma Multiforme. Radiation Research. 195(6). 549–560. 11 indexed citations
2.
Simone, Charles B., Molykutty John‐Aryankalayil, Sanjeewani T. Palayoor, et al.. (2013). mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status. Translational Oncology. 6(5). 573–585. 19 indexed citations
3.
Makinde, Adeola Y., Molykutty John‐Aryankalayil, Sanjeewani T. Palayoor, David Cerna, & C. Norman Coleman. (2012). Radiation Survivors: Understanding and Exploiting the Phenotype following Fractionated Radiation Therapy. Molecular Cancer Research. 11(1). 5–12. 28 indexed citations
4.
5.
Palayoor, Sanjeewani T., Adeola Y. Makinde, David Cerna, et al.. (2012). Gene Expression Profile of Coronary Artery Cells Treated With Nonsteroidal Anti-inflammatory Drugs Reveals Off-target Effects. Journal of Cardiovascular Pharmacology. 59(6). 487–499. 17 indexed citations
6.
John‐Aryankalayil, Molykutty, Sanjeewani T. Palayoor, Adeola Y. Makinde, et al.. (2012). Fractionated Radiation Alters Oncomir and Tumor Suppressor miRNAs in Human Prostate Cancer Cells. Radiation Research. 178(3). 105–105. 65 indexed citations
7.
John‐Aryankalayil, Molykutty, Sanjeewani T. Palayoor, David Cerna, et al.. (2010). Fractionated Radiation Therapy Can Induce a Molecular Profile for Therapeutic Targeting. Radiation Research. 174(4). 446–458. 49 indexed citations
8.
9.
John‐Aryankalayil, Molykutty, Sanjeewani T. Palayoor, David Cerna, et al.. (2009). NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells. Molecular Cancer Therapeutics. 8(1). 261–273. 36 indexed citations
10.
Jobson, Andrew G., G.T. Lountos, Philip L. Lorenzi, et al.. (2009). Cellular Inhibition of Checkpoint Kinase 2 (Chk2) and Potentiation of Camptothecins and Radiation by the Novel Chk2 Inhibitor PV1019 [7-Nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]. Journal of Pharmacology and Experimental Therapeutics. 331(3). 816–826. 81 indexed citations
11.
Jobson, Andrew G., G.T. Lountos, Philip L. Lorenzi, et al.. (2009). Cellular Inhibition of Checkpoint Kinase 2 (Chk2) and Potentiation of Camptothecins and Radiation by the Novel Chk2 Inhibitor PV1019 (7-Nitro-1H-indole-2-carboxylic acid. 1 indexed citations
12.
Chinnaiyan, Prakash, David Cerna, William Burgan, et al.. (2008). Postradiation Sensitization of the Histone Deacetylase Inhibitor Valproic Acid. Clinical Cancer Research. 14(17). 5410–5415. 87 indexed citations
13.
Palayoor, Sanjeewani T., James B. Mitchell, David Cerna, et al.. (2008). PX‐478, an inhibitor of hypoxia‐inducible factor‐1α, enhances radiosensitivity of prostate carcinoma cells. International Journal of Cancer. 123(10). 2430–2437. 107 indexed citations
14.
Kil, Whoon Jong, David Cerna, William Burgan, et al.. (2008). In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent Temozolomide. Clinical Cancer Research. 14(3). 931–938. 95 indexed citations
15.
Cerna, David, Kevin Camphausen, & Philip J. Tofilon. (2006). Histone Deacetylation as a Target for Radiosensitization. Current topics in developmental biology. 73. 173–204. 47 indexed citations
16.
Barker, Christopher A., William Burgan, David Cerna, et al.. (2006). In vitro and In vivo Radiosensitization Induced by the Ribonucleotide Reductase Inhibitor Triapine (3-Aminopyridine-2-Carboxaldehyde-Thiosemicarbazone). Clinical Cancer Research. 12(9). 2912–2918. 31 indexed citations
17.
Cerna, David & David K. Wilson. (2005). The Structure of Sif2p, a WD Repeat Protein Functioning in the SET3 Corepressor Complex. Journal of Molecular Biology. 351(4). 923–935. 43 indexed citations
18.
Wilson, David K., et al.. (2005). The 1.1-Å Structure of the Spindle Checkpoint Protein Bub3p Reveals Functional Regions. Journal of Biological Chemistry. 280(14). 13944–13951. 26 indexed citations
19.
Dote, Hideaki, David Cerna, William Burgan, et al.. (2005). Enhancement of In vitro and In vivo Tumor Cell Radiosensitivity by the DNA Methylation Inhibitor Zebularine. Clinical Cancer Research. 11(12). 4571–4579. 80 indexed citations
20.
Camphausen, Kevin, David Cerna, Tamalee Scott, et al.. (2004). Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid. International Journal of Cancer. 114(3). 380–386. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Estefanía Carrasco‐García Breakdown of academic impact, for papers by William Burgan Breakdown of academic impact, for papers by Sandaruwan Geeganage Breakdown of academic impact, for papers by Viney Jain Breakdown of academic impact, for papers by Hyun Min Jeon Breakdown of academic impact, for papers by Carmen Dekmezian Breakdown of academic impact, for papers by Gabriele D. Maurer Breakdown of academic impact, for papers by Yasir H. Ibrahim Breakdown of academic impact, for papers by Nathan G. Dolloff
Rankless by CCL
2026